Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M124,795Revenue $M15,250Net Margin (%)30.1Z-Score17.8
Enterprise Value $M123,988EPS $1.7Operating Margin %37.7F-Score6
P/E(ttm))26.0Cash Flow Per Share $5.2Pre-tax Margin (%)38.9Higher ROA y-yY
Price/Book20.510-y EBITDA Growth Rate %9.2Quick Ratio0.9Cash flow > EarningsN
Price/Sales8.05-y EBITDA Growth Rate %22.3Current Ratio1.3Lower Leverage y-yN
Price/Cash Flow30.9y-y EBITDA Growth Rate %9.7ROA % (ttm)35.8Higher Current Ratio y-yN
Dividend Yield %1.3Insider Buy (3m)0ROE % (ttm)59.2Less Shares Outstanding y-yY
Payout Ratio %34.0Shares Outstanding M2,750ROI % (ttm)69.1Gross Margin Increase y-yY

Gurus Latest Trades with NVO

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVORuane Cunniff 2014-03-31 Reduce-0.01%$36.722 - $48.23
($42.37)
$ 46.129%Reduce -21.98%242,630
NVORuane Cunniff 2013-12-31 Add0.02%$32.72 - $36.886
($34.84)
$ 46.1232%Add 58.71%62,194
NVORuane Cunniff 2013-06-30 Buy 0.04%$30.11 - $35.33
($33.29)
$ 46.1238%New holding, 34640 sh.34,640
NVOMario Gabelli 2013-03-31 Reduce$32.24 - $38.86
($34.93)
$ 46.1232%Reduce -60.32%1,734
NVOJohn Hussman 2012-09-30 Sold Out -0.01%$28.83 - $32.15
($30.65)
$ 46.1250%Sold Out0
NVOJohn Hussman 2012-03-31 Reduce$23.09 - $28.94
($24.82)
$ 46.1286%Reduce -40%3,000
NVOMario Gabelli 2011-12-31 Add$18.92 - $23.05
($21.5)
$ 46.12114%Add 66.87%5,590
NVOJohn Hussman 2011-09-30 Buy 0.01%$19.46 - $25.45
($22.27)
$ 46.12107%New holding, 5000 sh.5,000
NVOMario Gabelli 2011-06-30 Reduce$23.4 - $26.29
($24.91)
$ 46.1285%Reduce -21.18%3,350
NVOJohn Keeley 2011-06-30 Sold Out -0.01%$23.4 - $26.29
($24.91)
$ 46.1285%Sold Out0
NVOJohn Keeley 2010-12-31 Buy 0.01%$18.2 - $22.43
($20.77)
$ 46.12122%New holding, 2780 sh.2,780
NVOMario Gabelli 2010-09-30 Reduce$16.23 - $19.85
($17.64)
$ 46.12162%Reduce -28.77%4,420
NVOVanguard Health Care Fund 2010-09-30 Sold Out -0.19%$16.23 - $19.85
($17.64)
$ 46.12162%Sold Out0
NVOMario Gabelli 2010-06-30 Reduce$14.8 - $17.06
($15.97)
$ 46.12189%Reduce -56.26%6,205
NVOVanguard Health Care Fund 2010-06-30 Reduce-0.08%$14.8 - $17.06
($15.97)
$ 46.12189%Reduce -42.86%400,000
NVOTom Gayner 2010-03-31 Add0.31%$12.77 - $15.83
($14.23)
$ 46.12224%Add 39.04%231,500
NVOVanguard Health Care Fund 2010-03-31 Reduce-0.04%$12.77 - $15.83
($14.23)
$ 46.12224%Reduce -12.5%700,000
NVOTom Gayner 2009-12-31 Buy 0.75%$12.43 - $13.87
($13.03)
$ 46.12254%New holding, 166500 sh.166,500
NVOVanguard Health Care Fund 2008-03-31 Reduce-0.21%$11.58 - $13.52
($12.78)
$ 46.12261%Reduce -35.71%900,000
NVOVanguard Health Care Fund 2007-12-31 Add0.19%$11.56 - $13.31
($12.46)
$ 46.12270%Add 100%1,400,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVO is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
NVO Tom Gayner 2014-03-311,075,0000.041.5-2.8%
NVO Mario Gabelli 2014-03-317,66500-10.04%
NVO Ruane Cunniff 2014-03-31242,6300.010.06-21.98%
Premium Most recent portfolio changes are included for Premium Members only!


NVO: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about NVO :

    Quarterly/Annual Reports about NVO:

      News about NVO:

      Articles On GuruFocus.com
      GAMCO CIO Howard Ward on Reliable Consumer Stock Ideas Apr 09 2014 
      Assessing the New Boss at National Oilwell Varco Mar 31 2014 
      Amgen Inc: As Good as It Gets? Feb 20 2014 
      Shire PLC: Time to Panic? Feb 07 2014 
      Weekly 52-Week Highs Highlight: ACT, NVO, NXPI, WYNN Feb 03 2014 
      AstraZeneca: Time to Make a Bet? Steven Cohen Seems to Think It Is Jan 15 2014 
      Sanofi Continues to Struggle on Its Path to Recovery Nov 23 2013 
      Renaissance Man Jim Simons - A Tale of Three Pharmaceuticals and Remarkable Gains Jul 21 2013 
      Comment for Jan 27 2013 
      The 3 Most-Recommended Healthcare Stocks Jan 02 2013 


      Add Notes, Comments or Ask Questions

      User Comments

      Gintaras58
      ReplyGintaras58 - 4 months ago
      few excellent prducts to come soon
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK
      Email Hide